EIF4EBP1 and cancer: It has been reported that the genetic deletion of 4EBP1 and 4EBP2 significantly accelerate all phases of cancer development in the context of PTEN loss-driven prostate cancer in mice despite potent PI3K/AKT and mTOR activation (Ding et al., 2018).